Related Experiment Video
Updated: Jul 20, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Drug evaluation: Albuferon-alpha--an antiviral interferon-alpha/albumin fusion protein
Annie T Chemmanur1, George Y Wu
1University of Connecticut Health Center, Department of Medicine, Division of Gastroenterology-Hepatology, Farmington, CT 06030-1845, USA.
Abstract:
Human Genome Sciences Inc (HGS), in collaboration with Novartis AG, is developing Albuferon-alpha, a long-acting injectable human interferon alpha2b fusion protein, for the potential treatment of hepatitis C virus (HCV) infection. By May 2004, phase II clinical trials of Albuferon in HCV infection were underway. In June 2006, HGS planned to initiate phase III clinical trials in this indication by the end of 2006. Albuferon also has the potential to treat a broad range of cancers.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Respiratory Syncytial Virus Disease
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Inhibitors Of Virion Release
